![Sumi Biswas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Sumi Biswas.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Spybiotech Ltd.
![]() Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom.
10
| Holding Company | Biotechnology | 10 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Sumi Biswas a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Genelabs Technologies, Inc.
![]() Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alta Partners Management Co. LP
![]() Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Private Equity Investor | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Chief Executive Officer | |
ACUSPHERE, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
CHIASMA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Paloma Pharmaceuticals, Inc.
![]() Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Pharmaceuticals: Major | Director/Board Member | |
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Chief Executive Officer | |
Zyngenia, Inc.
![]() Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
MORPHOSYS AG | Biotechnology | Corporate Officer/Principal | |
Capricorn Partners NV
![]() Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor | |
University of London | College/University | Undergraduate Degree | |
University of Wisconsin | College/University | Doctorate Degree | |
Moscow State University Lomonosov | College/University | Undergraduate Degree | |
Grifols Therapeutics, Inc.
![]() Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | Biotechnology | Corporate Officer/Principal | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
ABLYNX | Biotechnology | Director/Board Member | |
APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Corporate Officer/Principal | |
NEXSTIM PLC | Medical Specialties | Director/Board Member | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Talecris Biotherapeutics Holdings Corp.
![]() Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Biotechnology | Corporate Officer/Principal | |
Genset Corp.
![]() Genset Corp. Pharmaceuticals: MajorHealth Technology Founded in 1992, Genset Corp. is a pharmaceutical company that manufactures and markets pharmaceuticals. The company is based in San Diego, CA and is a part of Merck KGaA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
European Private Equity & Venture Capital Association | Director/Board Member | ||
Cerenis Therapeutics, Inc.
![]() Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
ADOCIA | Pharmaceuticals: Major | Director/Board Member | |
NeuroHealing Pharmaceuticals, Inc.
![]() NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA. | Pharmaceuticals: Major | Director/Board Member | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Sales & Marketing | |
British Pharma Group Ltd. | Director/Board Member | ||
Independent Press Standards Organisation CIC | General Government | Director/Board Member | |
The University of North Carolina at Charlotte | College/University | Masters Business Admin | |
iSTAR Medical SA
![]() iSTAR Medical SA Medical SpecialtiesHealth Technology iSTAR Medical SA develops innovative ophthalmic implants. Its products include MINIject, STARflo and STAR Material. The company was founded by Michel Alvarez in 2011 and is headquartered in Wavre, Belgium. | Medical Specialties | Director/Board Member | |
Yale School of Management | College/University | Masters Business Admin | |
XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman | |
Oxford Science Enterprises PLC
![]() Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Confo Therapeutics NV
![]() Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Oxford Nanoimaging Ltd.
![]() Oxford Nanoimaging Ltd. Packaged SoftwareTechnology Services Oxford Nanoimaging Ltd. develops and researches intelligent software and fluorescence microscopy image cells. The company was founded by Achillefs Kapanidis and Bo Jing on February 24, 2016 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Director/Board Member Director/Board Member | |
MiroBio Ltd.
![]() MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
Cranfield School of Management | College/University | Masters Business Admin | |
Smithkline Beecham Pharmaceuticals (Canada) | Sales & Marketing | ||
Aleta Biotherapeutics, Inc.
![]() Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Chairman | |
Eterna Therapeutics LLC
![]() Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Eterna Therapeutics, Inc., Eterna Therapeutics LLC is a clinical-stage biopharmaceutical company based in New York, NY. The company is focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer. Eterna Therapeutics is committed to developing irx-2, a novel cytokine-based therapy, to treat patients with cancer. The active constituents of irx-2, namely interleukin-2 (il-2) and other key cytokines, are postulated to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. Eterna Therapeutics is a late clinical-stage biopharmaceutical company focused on il-2 cytokine-based therapies in treating patients with cancer. Eterna Therapeutics was acquired by NTN Buzztime, Inc. on March 25, 2021 for $213.30 million. | Pharmaceuticals: Major | Chief Executive Officer |
Estadísticas
Internacional
Estados Unidos | 27 |
Reino Unido | 9 |
Bélgica | 6 |
Francia | 5 |
Alemania | 4 |
Sectorial
Health Technology | 32 |
Consumer Services | 8 |
Finance | 4 |
Commercial Services | 3 |
Retail Trade | 2 |
Operativa
Director/Board Member | 45 |
Corporate Officer/Principal | 15 |
Chief Executive Officer | 12 |
President | 9 |
Founder | 9 |
Las relaciones más conectadas
Insiders | |
---|---|
Mark Leuchtenberger | 21 |
Lutz B. Giebel | 21 |
Ekaterina Smirnyagina | 21 |
Daniel L. Menichella | 13 |
Eddie J. Gray | 10 |
Lachlan Tom Mackinnon | 3 |
Mark Howarth | 1 |
Simon J Draper | 1 |
Jing Jin | 1 |
James Wong | 1 |
- Bolsa de valores
- Insiders
- Sumi Biswas
- Conexiones Empresas